APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rifaximin Tablets

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Rifaximin Tablets Market Analysis and Forecast 2026-2032

27 December 2025204 pages

Choose your research edition.

Industry ResearchRifaximin Tablets Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Rifaximin Tablets Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Rifaximin Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rifaximin Tablets Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Rifaximin Tablets Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Rifaximin Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Rifaximin Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Rifaximin Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Rifaximin Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Rifaximin Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Rifaximin Tablets include Aden Healthcare, Alfasigma SpA, AS Lifesciences, Estrellas Life Sciences Private Limited, Gnova Biotech, Healthy Life Pharma Pvt. Ltd., Netprime Pharma, Norgine Limited and Nanchang Feihong Pharmaceutical Co., Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Rifaximin Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Rifaximin Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Rifaximin Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Rifaximin Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Rifaximin Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Rifaximin Tablets sales, projected growth trends, production technology, application and end-user industry.

Rifaximin Tablets Segment by Company

Aden Healthcare

Alfasigma SpA

AS Lifesciences

Estrellas Life Sciences Private Limited

Gnova Biotech

Healthy Life Pharma Pvt. Ltd.

Netprime Pharma

Norgine Limited

Nanchang Feihong Pharmaceutical Co., Ltd.

Shandong Zibo Xinda Pharmaceutical Co., Ltd.

Shaanxi Kaiyuan Pharmaceutical Co., Ltd.

Shenyang Tonglian Pharmaceutical Co., Ltd.

Sichuan Baili Pharmaceutical Co., Ltd.

Sichuan Mingxing Pharmaceutical Co., Ltd.

Tianjin Junan Biopharmaceutical Co., Ltd.

Chongqing Laimi Pharmaceutical Co., Ltd.

Chongqing Sino Biopharmaceutical Co., Ltd.

Rifaximin Tablets Segment by Type

0.1g

0.2g

Rifaximin Tablets Segment by Application

Clinic

Hospital

Other

Rifaximin Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rifaximin Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rifaximin Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rifaximin Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Rifaximin Tablets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Rifaximin Tablets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rifaximin Tablets sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Rifaximin Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 0.1g Major Manufacturers Table 3. 0.2g Major Manufacturers Table 4. Global Rifaximin Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Clinic Major Manufacturers Table 6. Hospital Major Manufacturers Table 7. Other Major Manufacturers Table 8. Rifaximin Tablets Industry Trends Table 9. Rifaximin Tablets Industry Drivers Table 10. Rifaximin Tablets Industry Opportunities and Challenges Table 11. Rifaximin Tablets Industry Restraints Table 12. Global Rifaximin Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Rifaximin Tablets Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Rifaximin Tablets Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Rifaximin Tablets Revenue Market Share by Region (2021-2026) Table 16. Global Rifaximin Tablets Revenue Market Share by Region (2027-2032) Table 17. Global Rifaximin Tablets Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Rifaximin Tablets Sales by Region (2021-2026) & (K Units) Table 19. Global Rifaximin Tablets Sales by Region (2027-2032) & (K Units) Table 20. Global Rifaximin Tablets Sales Market Share by Region (2021-2026) Table 21. Global Rifaximin Tablets Sales Market Share by Region (2027-2032) Table 22. Global Rifaximin Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Rifaximin Tablets Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Rifaximin Tablets Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Rifaximin Tablets Sales Market Share by Manufacturers (2021-2026) Table 26. Global Rifaximin Tablets Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Rifaximin Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Rifaximin Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Rifaximin Tablets Manufacturers, Product Type & Application Table 30. Global Rifaximin Tablets Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Rifaximin Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Rifaximin Tablets Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Rifaximin Tablets Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Rifaximin Tablets Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Rifaximin Tablets Revenue Market Share by Type (2021-2026) Table 37. Global Rifaximin Tablets Revenue Market Share by Type (2027-2032) Table 38. Global Rifaximin Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Rifaximin Tablets Sales by Type (2021-2026) & (K Units) Table 40. Global Rifaximin Tablets Sales by Type (2027-2032) & (K Units) Table 41. Global Rifaximin Tablets Sales Market Share by Type (2021-2026) Table 42. Global Rifaximin Tablets Sales Market Share by Type (2027-2032) Table 43. Global Rifaximin Tablets Price by Type (2021-2026) & (US$/Unit) Table 44. Global Rifaximin Tablets Price by Type (2027-2032) & (US$/Unit) Table 45. Global Rifaximin Tablets Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Rifaximin Tablets Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Rifaximin Tablets Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Rifaximin Tablets Revenue Market Share by Application (2021-2026) Table 49. Global Rifaximin Tablets Revenue Market Share by Application (2027-2032) Table 50. Global Rifaximin Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Rifaximin Tablets Sales by Application (2021-2026) & (K Units) Table 52. Global Rifaximin Tablets Sales by Application (2027-2032) & (K Units) Table 53. Global Rifaximin Tablets Sales Market Share by Application (2021-2026) Table 54. Global Rifaximin Tablets Sales Market Share by Application (2027-2032) Table 55. Global Rifaximin Tablets Price by Application (2021-2026) & (US$/Unit) Table 56. Global Rifaximin Tablets Price by Application (2027-2032) & (US$/Unit) Table 57. Aden Healthcare Company Information Table 58. Aden Healthcare Business Overview Table 59. Aden Healthcare Rifaximin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Aden Healthcare Rifaximin Tablets Product Portfolio Table 61. Aden Healthcare Recent Development Table 62. Alfasigma SpA Company Information Table 63. Alfasigma SpA Business Overview Table 64. Alfasigma SpA Rifaximin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Alfasigma SpA Rifaximin Tablets Product Portfolio Table 66. Alfasigma SpA Recent Development Table 67. AS Lifesciences Company Information Table 68. AS Lifesciences Business Overview Table 69. AS Lifesciences Rifaximin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. AS Lifesciences Rifaximin Tablets Product Portfolio Table 71. AS Lifesciences Recent Development Table 72. Estrellas Life Sciences Private Limited Company Information Table 73. Estrellas Life Sciences Private Limited Business Overview Table 74. Estrellas Life Sciences Private Limited Rifaximin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Estrellas Life Sciences Private Limited Rifaximin Tablets Product Portfolio Table 76. Estrellas Life Sciences Private Limited Recent Development Table 77. Gnova Biotech Company Information Table 78. Gnova Biotech Business Overview Table 79. Gnova Biotech Rifaximin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Gnova Biotech Rifaximin Tablets Product Portfolio Table 81. Gnova Biotech Recent Development Table 82. Healthy Life Pharma Pvt. Ltd. Company Information Table 83. Healthy Life Pharma Pvt. Ltd. Business Overview Table 84. Healthy Life Pharma Pvt. Ltd. Rifaximin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Healthy Life Pharma Pvt. Ltd. Rifaximin Tablets Product Portfolio Table 86. Healthy Life Pharma Pvt. Ltd. Recent Development Table 87. Netprime Pharma Company Information Table 88. Netprime Pharma Business Overview Table 89. Netprime Pharma Rifaximin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Netprime Pharma Rifaximin Tablets Product Portfolio Table 91. Netprime Pharma Recent Development Table 92. Norgine Limited Company Information Table 93. Norgine Limited Business Overview Table 94. Norgine Limited Rifaximin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Norgine Limited Rifaximin Tablets Product Portfolio Table 96. Norgine Limited Recent Development Table 97. Nanchang Feihong Pharmaceutical Co., Ltd. Company Information Table 98. Nanchang Feihong Pharmaceutical Co., Ltd. Business Overview Table 99. Nanchang Feihong Pharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Nanchang Feihong Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio Table 101. Nanchang Feihong Pharmaceutical Co., Ltd. Recent Development Table 102. Shandong Zibo Xinda Pharmaceutical Co., Ltd. Company Information Table 103. Shandong Zibo Xinda Pharmaceutical Co., Ltd. Business Overview Table 104. Shandong Zibo Xinda Pharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Shandong Zibo Xinda Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio Table 106. Shandong Zibo Xinda Pharmaceutical Co., Ltd. Recent Development Table 107. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Company Information Table 108. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Business Overview Table 109. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio Table 111. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Recent Development Table 112. Shenyang Tonglian Pharmaceutical Co., Ltd. Company Information Table 113. Shenyang Tonglian Pharmaceutical Co., Ltd. Business Overview Table 114. Shenyang Tonglian Pharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Shenyang Tonglian Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio Table 116. Shenyang Tonglian Pharmaceutical Co., Ltd. Recent Development Table 117. Sichuan Baili Pharmaceutical Co., Ltd. Company Information Table 118. Sichuan Baili Pharmaceutical Co., Ltd. Business Overview Table 119. Sichuan Baili Pharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Sichuan Baili Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio Table 121. Sichuan Baili Pharmaceutical Co., Ltd. Recent Development Table 122. Sichuan Mingxing Pharmaceutical Co., Ltd. Company Information Table 123. Sichuan Mingxing Pharmaceutical Co., Ltd. Business Overview Table 124. Sichuan Mingxing Pharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Sichuan Mingxing Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio Table 126. Sichuan Mingxing Pharmaceutical Co., Ltd. Recent Development Table 127. Tianjin Junan Biopharmaceutical Co., Ltd. Company Information Table 128. Tianjin Junan Biopharmaceutical Co., Ltd. Business Overview Table 129. Tianjin Junan Biopharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Tianjin Junan Biopharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio Table 131. Tianjin Junan Biopharmaceutical Co., Ltd. Recent Development Table 132. Chongqing Laimi Pharmaceutical Co., Ltd. Company Information Table 133. Chongqing Laimi Pharmaceutical Co., Ltd. Business Overview Table 134. Chongqing Laimi Pharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Chongqing Laimi Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio Table 136. Chongqing Laimi Pharmaceutical Co., Ltd. Recent Development Table 137. Chongqing Sino Biopharmaceutical Co., Ltd. Company Information Table 138. Chongqing Sino Biopharmaceutical Co., Ltd. Business Overview Table 139. Chongqing Sino Biopharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Chongqing Sino Biopharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio Table 141. Chongqing Sino Biopharmaceutical Co., Ltd. Recent Development Table 142. North America Rifaximin Tablets Revenue by Type (2021-2026) & (US$ Million) Table 143. North America Rifaximin Tablets Revenue by Type (2027-2032) & (US$ Million) Table 144. North America Rifaximin Tablets Sales by Type (2021-2026) & (K Units) Table 145. North America Rifaximin Tablets Sales by Type (2027-2032) & (K Units) Table 146. North America Rifaximin Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 147. North America Rifaximin Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 148. North America Rifaximin Tablets Revenue by Application (2021-2026) & (US$ Million) Table 149. North America Rifaximin Tablets Revenue by Application (2027-2032) & (US$ Million) Table 150. North America Rifaximin Tablets Sales by Application (2021-2026) & (K Units) Table 151. North America Rifaximin Tablets Sales by Application (2027-2032) & (K Units) Table 152. North America Rifaximin Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 153. North America Rifaximin Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 154. North America Rifaximin Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. North America Rifaximin Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 156. North America Rifaximin Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 157. North America Rifaximin Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 158. North America Rifaximin Tablets Sales by Country (2021-2026) & (K Units) Table 159. North America Rifaximin Tablets Sales by Country (2027-2032) & (K Units) Table 160. North America Rifaximin Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 161. North America Rifaximin Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 162. United States Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Table 163. Canada Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Table 164. Mexico Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Table 165. Europe Rifaximin Tablets Revenue by Type (2021-2026) & (US$ Million) Table 166. Europe Rifaximin Tablets Revenue by Type (2027-2032) & (US$ Million) Table 167. Europe Rifaximin Tablets Sales by Type (2021-2026) & (K Units) Table 168. Europe Rifaximin Tablets Sales by Type (2027-2032) & (K Units) Table 169. Europe Rifaximin Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 170. Europe Rifaximin Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 171. Europe Rifaximin Tablets Revenue by Application (2021-2026) & (US$ Million) Table 172. Europe Rifaximin Tablets Revenue by Application (2027-2032) & (US$ Million) Table 173. Europe Rifaximin Tablets Sales by Application (2021-2026) & (K Units) Table 174. Europe Rifaximin Tablets Sales by Application (2027-2032) & (K Units) Table 175. Europe Rifaximin Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 176. Europe Rifaximin Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 177. Europe Rifaximin Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 178. Europe Rifaximin Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 179. Europe Rifaximin Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 180. Europe Rifaximin Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 181. Europe Rifaximin Tablets Sales by Country (2021-2026) & (K Units) Table 182. Europe Rifaximin Tablets Sales by Country (2027-2032) & (K Units) Table 183. Europe Rifaximin Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 184. Europe Rifaximin Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 185. Germany Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Table 186. France Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Table 187. U.K. Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Table 188. Italy Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Table 189. Russia Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Table 190. Spain Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Table 191. Netherlands Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Table 192. Switzerland Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Table 193. Sweden Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Table 194. Poland Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Table 195. China Rifaximin Tablets Revenue by Type (2021-2026) & (US$ Million) Table 196. China Rifaximin Tablets Revenue by Type (2027-2032) & (US$ Million) Table 197. China Rifaximin Tablets Sales by Type (2021-2026) & (K Units) Table 198. China Rifaximin Tablets Sales by Type (2027-2032) & (K Units) Table 199. China Rifaximin Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 200. China Rifaximin Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 201. China Rifaximin Tablets Revenue by Application (2021-2026) & (US$ Million) Table 202. China Rifaximin Tablets Revenue by Application (2027-2032) & (US$ Million) Table 203. China Rifaximin Tablets Sales by Application (2021-2026) & (K Units) Table 204. China Rifaximin Tablets Sales by Application (2027-2032) & (K Units) Table 205. China Rifaximin Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 206. China Rifaximin Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 207. Asia Rifaximin Tablets Revenue by Type (2021-2026) & (US$ Million) Table 208. Asia Rifaximin Tablets Revenue by Type (2027-2032) & (US$ Million) Table 209. Asia Rifaximin Tablets Sales by Type (2021-2026) & (K Units) Table 210. Asia Rifaximin Tablets Sales by Type (2027-2032) & (K Units) Table 211. Asia Rifaximin Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 212. Asia Rifaximin Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 213. Asia Rifaximin Tablets Revenue by Application (2021-2026) & (US$ Million) Table 214. Asia Rifaximin Tablets Revenue by Application (2027-2032) & (US$ Million) Table 215. Asia Rifaximin Tablets Sales by Application (2021-2026) & (K Units) Table 216. Asia Rifaximin Tablets Sales by Application (2027-2032) & (K Units) Table 217. Asia Rifaximin Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 218. Asia Rifaximin Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 219. Asia Rifaximin Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 220. Asia Rifaximin Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 221. Asia Rifaximin Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 222. Asia Rifaximin Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 223. Asia Rifaximin Tablets Sales by Country (2021-2026) & (K Units) Table 224. Asia Rifaximin Tablets Sales by Country (2027-2032) & (K Units) Table 225. Asia Rifaximin Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 226. Asia Rifaximin Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 227. Japan Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Table 228. South Korea Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Table 229. India Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Table 230. Australia Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Table 231. Taiwan Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Table 232. Southeast Asia Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Table 233. SAMEA Rifaximin Tablets Revenue by Type (2021-2026) & (US$ Million) Table 234. SAMEA Rifaximin Tablets Revenue by Type (2027-2032) & (US$ Million) Table 235. SAMEA Rifaximin Tablets Sales by Type (2021-2026) & (K Units) Table 236. SAMEA Rifaximin Tablets Sales by Type (2027-2032) & (K Units) Table 237. SAMEA Rifaximin Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 238. SAMEA Rifaximin Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 239. SAMEA Rifaximin Tablets Revenue by Application (2021-2026) & (US$ Million) Table 240. SAMEA Rifaximin Tablets Revenue by Application (2027-2032) & (US$ Million) Table 241. SAMEA Rifaximin Tablets Sales by Application (2021-2026) & (K Units) Table 242. SAMEA Rifaximin Tablets Sales by Application (2027-2032) & (K Units) Table 243. SAMEA Rifaximin Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 244. SAMEA Rifaximin Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 245. SAMEA Rifaximin Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 246. SAMEA Rifaximin Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 247. SAMEA Rifaximin Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 248. SAMEA Rifaximin Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 249. SAMEA Rifaximin Tablets Sales by Country (2021-2026) & (K Units) Table 250. SAMEA Rifaximin Tablets Sales by Country (2027-2032) & (K Units) Table 251. SAMEA Rifaximin Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 252. SAMEA Rifaximin Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 253. Brazil Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Table 254. Argentina Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Table 255. Chile Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Table 256. Colombia Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Table 257. Peru Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Table 258. Saudi Arabia Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Table 259. Israel Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Table 260. UAE Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Table 261. Turkey Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Table 262. Iran Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Table 263. Egypt Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Table 264. Key Raw Materials Table 265. Raw Materials Key Suppliers Table 266. Rifaximin Tablets Distributors List Table 267. Rifaximin Tablets Customers List Table 268. Research Programs/Design for This Report Table 269. Authors List of This Report Table 270. Secondary Sources Table 271. Primary Sources List of Figures Figure 1. Rifaximin Tablets Image Figure 2. Global Rifaximin Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rifaximin Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 4. 0.1g Image Figure 5. 0.2g Image Figure 6. Global Rifaximin Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Rifaximin Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 8. Clinic Image Figure 9. Hospital Image Figure 10. Other Image Figure 11. Global Rifaximin Tablets Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Rifaximin Tablets Revenue (2021-2032) & (US$ Million) Figure 13. Global Rifaximin Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Rifaximin Tablets Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Rifaximin Tablets Revenue Market Share by Region (2021-2032) Figure 16. Global Rifaximin Tablets Sales (2021-2032) & (K Units) Figure 17. Global Rifaximin Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Rifaximin Tablets Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Rifaximin Tablets Sales YoY (2021-2032) & (K Units) Figure 20. Europe Rifaximin Tablets Sales YoY (2021-2032) & (K Units) Figure 21. China Rifaximin Tablets Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Rifaximin Tablets Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Rifaximin Tablets Sales YoY (2021-2032) & (K Units) Figure 24. Global Rifaximin Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Rifaximin Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Rifaximin Tablets Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Rifaximin Tablets Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Rifaximin Tablets Revenue Market Share by Type (2021-2032) Figure 30. Global Rifaximin Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Rifaximin Tablets Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Rifaximin Tablets Sales Market Share by Type (2021-2032) Figure 33. Global Rifaximin Tablets Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Rifaximin Tablets Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Rifaximin Tablets Revenue Market Share by Application (2021-2032) Figure 36. Global Rifaximin Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Rifaximin Tablets Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Rifaximin Tablets Sales Market Share by Application (2021-2032) Figure 39. North America Rifaximin Tablets Revenue Share by Type (2021-2032) Figure 40. North America Rifaximin Tablets Sales Share by Type (2021-2032) Figure 41. North America Rifaximin Tablets Revenue Share by Application (2021-2032) Figure 42. North America Rifaximin Tablets Sales Share by Application (2021-2032) Figure 43. North America Rifaximin Tablets Revenue Share by Country (2021-2032) Figure 44. North America Rifaximin Tablets Sales Share by Country (2021-2032) Figure 45. Europe Rifaximin Tablets Revenue Share by Type (2021-2032) Figure 46. Europe Rifaximin Tablets Sales Share by Type (2021-2032) Figure 47. Europe Rifaximin Tablets Revenue Share by Application (2021-2032) Figure 48. Europe Rifaximin Tablets Sales Share by Application (2021-2032) Figure 49. Europe Rifaximin Tablets Revenue Share by Country (2021-2032) Figure 50. Europe Rifaximin Tablets Sales Share by Country (2021-2032) Figure 51. China Rifaximin Tablets Revenue Share by Type (2021-2032) Figure 52. China Rifaximin Tablets Sales Share by Type (2021-2032) Figure 53. China Rifaximin Tablets Revenue Share by Application (2021-2032) Figure 54. China Rifaximin Tablets Sales Share by Application (2021-2032) Figure 55. Asia Rifaximin Tablets Revenue Share by Type (2021-2032) Figure 56. Asia Rifaximin Tablets Sales Share by Type (2021-2032) Figure 57. Asia Rifaximin Tablets Revenue Share by Application (2021-2032) Figure 58. Asia Rifaximin Tablets Sales Share by Application (2021-2032) Figure 59. Asia Rifaximin Tablets Revenue Share by Country (2021-2032) Figure 60. Asia Rifaximin Tablets Sales Share by Country (2021-2032) Figure 61. SAMEA Rifaximin Tablets Revenue Share by Type (2021-2032) Figure 62. SAMEA Rifaximin Tablets Sales Share by Type (2021-2032) Figure 63. SAMEA Rifaximin Tablets Revenue Share by Application (2021-2032) Figure 64. SAMEA Rifaximin Tablets Sales Share by Application (2021-2032) Figure 65. SAMEA Rifaximin Tablets Revenue Share by Country (2021-2032) Figure 66. SAMEA Rifaximin Tablets Sales Share by Country (2021-2032) Figure 67. Rifaximin Tablets Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Rifaximin Tablets Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 0.1g
  • 0.2g
Applications
  • Clinic
  • Hospital
  • Other
Companies covered
  • Aden Healthcare
  • Alfasigma SpA
  • AS Lifesciences
  • Estrellas Life Sciences Private Limited
  • Gnova Biotech
  • Healthy Life Pharma Pvt. Ltd.
  • Netprime Pharma
  • Norgine Limited
  • Nanchang Feihong Pharmaceutical Co., Ltd.
  • Shandong Zibo Xinda Pharmaceutical Co., Ltd.
  • Shaanxi Kaiyuan Pharmaceutical Co., Ltd.
  • Shenyang Tonglian Pharmaceutical Co., Ltd.
  • Sichuan Baili Pharmaceutical Co., Ltd.
  • Sichuan Mingxing Pharmaceutical Co., Ltd.
  • Tianjin Junan Biopharmaceutical Co., Ltd.
  • Chongqing Laimi Pharmaceutical Co., Ltd.
  • Chongqing Sino Biopharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Rifaximin Tablets Market by Type
  3. 1.2.1 Global Rifaximin Tablets Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 0.1g
  5. 1.2.3 0.2g
  6. 1.3 Rifaximin Tablets Market by Application
  7. 1.3.1 Global Rifaximin Tablets Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Clinic
  9. 1.3.3 Hospital
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Rifaximin Tablets Market Dynamics
  1. 2.1 Rifaximin Tablets Industry Trends
  2. 2.2 Rifaximin Tablets Industry Drivers
  3. 2.3 Rifaximin Tablets Industry Opportunities and Challenges
  4. 2.4 Rifaximin Tablets Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Rifaximin Tablets Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Rifaximin Tablets Revenue by Region
  3. 3.2.1 Global Rifaximin Tablets Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Rifaximin Tablets Revenue by Region (2021-2026)
  5. 3.2.3 Global Rifaximin Tablets Revenue by Region (2027-2032)
  6. 3.2.4 Global Rifaximin Tablets Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Rifaximin Tablets Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Rifaximin Tablets Sales by Region
  9. 3.4.1 Global Rifaximin Tablets Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Rifaximin Tablets Sales by Region (2021-2026)
  11. 3.4.3 Global Rifaximin Tablets Sales by Region (2027-2032)
  12. 3.4.4 Global Rifaximin Tablets Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Rifaximin Tablets Revenue by Manufacturers
  2. 4.1.1 Global Rifaximin Tablets Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Rifaximin Tablets Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Rifaximin Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Rifaximin Tablets Sales by Manufacturers
  6. 4.2.1 Global Rifaximin Tablets Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Rifaximin Tablets Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Rifaximin Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Rifaximin Tablets Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Rifaximin Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Rifaximin Tablets Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Rifaximin Tablets Manufacturers, Product Type & Application
  13. 4.7 Global Rifaximin Tablets Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Rifaximin Tablets Market CR5 and HHI
  16. 4.8.2 2025 Rifaximin Tablets Tier 1, Tier 2, and Tier 3
5 Rifaximin Tablets Market by Type
  1. 5.1 Global Rifaximin Tablets Revenue by Type
  2. 5.1.1 Global Rifaximin Tablets Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Rifaximin Tablets Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Rifaximin Tablets Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Rifaximin Tablets Sales by Type
  6. 5.2.1 Global Rifaximin Tablets Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Rifaximin Tablets Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Rifaximin Tablets Sales Market Share by Type (2021-2032)
  9. 5.3 Global Rifaximin Tablets Price by Type
6 Rifaximin Tablets Market by Application
  1. 6.1 Global Rifaximin Tablets Revenue by Application
  2. 6.1.1 Global Rifaximin Tablets Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Rifaximin Tablets Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Rifaximin Tablets Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Rifaximin Tablets Sales by Application
  6. 6.2.1 Global Rifaximin Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Rifaximin Tablets Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Rifaximin Tablets Sales Market Share by Application (2021-2032)
  9. 6.3 Global Rifaximin Tablets Price by Application
7 Company Profiles
  1. 7.1 Aden Healthcare
  2. 7.1.1 Aden Healthcare Company Information
  3. 7.1.2 Aden Healthcare Business Overview
  4. 7.1.3 Aden Healthcare Rifaximin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Aden Healthcare Rifaximin Tablets Product Portfolio
  6. 7.1.5 Aden Healthcare Recent Developments
  7. 7.2 Alfasigma SpA
  8. 7.2.1 Alfasigma SpA Company Information
  9. 7.2.2 Alfasigma SpA Business Overview
  10. 7.2.3 Alfasigma SpA Rifaximin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Alfasigma SpA Rifaximin Tablets Product Portfolio
  12. 7.2.5 Alfasigma SpA Recent Developments
  13. 7.3 AS Lifesciences
  14. 7.3.1 AS Lifesciences Company Information
  15. 7.3.2 AS Lifesciences Business Overview
  16. 7.3.3 AS Lifesciences Rifaximin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 AS Lifesciences Rifaximin Tablets Product Portfolio
  18. 7.3.5 AS Lifesciences Recent Developments
  19. 7.4 Estrellas Life Sciences Private Limited
  20. 7.4.1 Estrellas Life Sciences Private Limited Company Information
  21. 7.4.2 Estrellas Life Sciences Private Limited Business Overview
  22. 7.4.3 Estrellas Life Sciences Private Limited Rifaximin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Estrellas Life Sciences Private Limited Rifaximin Tablets Product Portfolio
  24. 7.4.5 Estrellas Life Sciences Private Limited Recent Developments
  25. 7.5 Gnova Biotech
  26. 7.5.1 Gnova Biotech Company Information
  27. 7.5.2 Gnova Biotech Business Overview
  28. 7.5.3 Gnova Biotech Rifaximin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Gnova Biotech Rifaximin Tablets Product Portfolio
  30. 7.5.5 Gnova Biotech Recent Developments
  31. 7.6 Healthy Life Pharma Pvt. Ltd.
  32. 7.6.1 Healthy Life Pharma Pvt. Ltd. Company Information
  33. 7.6.2 Healthy Life Pharma Pvt. Ltd. Business Overview
  34. 7.6.3 Healthy Life Pharma Pvt. Ltd. Rifaximin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Healthy Life Pharma Pvt. Ltd. Rifaximin Tablets Product Portfolio
  36. 7.6.5 Healthy Life Pharma Pvt. Ltd. Recent Developments
  37. 7.7 Netprime Pharma
  38. 7.7.1 Netprime Pharma Company Information
  39. 7.7.2 Netprime Pharma Business Overview
  40. 7.7.3 Netprime Pharma Rifaximin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Netprime Pharma Rifaximin Tablets Product Portfolio
  42. 7.7.5 Netprime Pharma Recent Developments
  43. 7.8 Norgine Limited
  44. 7.8.1 Norgine Limited Company Information
  45. 7.8.2 Norgine Limited Business Overview
  46. 7.8.3 Norgine Limited Rifaximin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Norgine Limited Rifaximin Tablets Product Portfolio
  48. 7.8.5 Norgine Limited Recent Developments
  49. 7.9 Nanchang Feihong Pharmaceutical Co., Ltd.
  50. 7.9.1 Nanchang Feihong Pharmaceutical Co., Ltd. Company Information
  51. 7.9.2 Nanchang Feihong Pharmaceutical Co., Ltd. Business Overview
  52. 7.9.3 Nanchang Feihong Pharmaceutical Co., Ltd. Rifaximin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Nanchang Feihong Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio
  54. 7.9.5 Nanchang Feihong Pharmaceutical Co., Ltd. Recent Developments
  55. 7.10 Shandong Zibo Xinda Pharmaceutical Co., Ltd.
  56. 7.10.1 Shandong Zibo Xinda Pharmaceutical Co., Ltd. Company Information
  57. 7.10.2 Shandong Zibo Xinda Pharmaceutical Co., Ltd. Business Overview
  58. 7.10.3 Shandong Zibo Xinda Pharmaceutical Co., Ltd. Rifaximin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Shandong Zibo Xinda Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio
  60. 7.10.5 Shandong Zibo Xinda Pharmaceutical Co., Ltd. Recent Developments
  61. 7.11 Shaanxi Kaiyuan Pharmaceutical Co., Ltd.
  62. 7.11.1 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Company Information
  63. 7.11.2 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Business Overview
  64. 7.11.3 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Rifaximin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio
  66. 7.11.5 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Recent Developments
  67. 7.12 Shenyang Tonglian Pharmaceutical Co., Ltd.
  68. 7.12.1 Shenyang Tonglian Pharmaceutical Co., Ltd. Company Information
  69. 7.12.2 Shenyang Tonglian Pharmaceutical Co., Ltd. Business Overview
  70. 7.12.3 Shenyang Tonglian Pharmaceutical Co., Ltd. Rifaximin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Shenyang Tonglian Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio
  72. 7.12.5 Shenyang Tonglian Pharmaceutical Co., Ltd. Recent Developments
  73. 7.13 Sichuan Baili Pharmaceutical Co., Ltd.
  74. 7.13.1 Sichuan Baili Pharmaceutical Co., Ltd. Company Information
  75. 7.13.2 Sichuan Baili Pharmaceutical Co., Ltd. Business Overview
  76. 7.13.3 Sichuan Baili Pharmaceutical Co., Ltd. Rifaximin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Sichuan Baili Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio
  78. 7.13.5 Sichuan Baili Pharmaceutical Co., Ltd. Recent Developments
  79. 7.14 Sichuan Mingxing Pharmaceutical Co., Ltd.
  80. 7.14.1 Sichuan Mingxing Pharmaceutical Co., Ltd. Company Information
  81. 7.14.2 Sichuan Mingxing Pharmaceutical Co., Ltd. Business Overview
  82. 7.14.3 Sichuan Mingxing Pharmaceutical Co., Ltd. Rifaximin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Sichuan Mingxing Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio
  84. 7.14.5 Sichuan Mingxing Pharmaceutical Co., Ltd. Recent Developments
  85. 7.15 Tianjin Junan Biopharmaceutical Co., Ltd.
  86. 7.15.1 Tianjin Junan Biopharmaceutical Co., Ltd. Company Information
  87. 7.15.2 Tianjin Junan Biopharmaceutical Co., Ltd. Business Overview
  88. 7.15.3 Tianjin Junan Biopharmaceutical Co., Ltd. Rifaximin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Tianjin Junan Biopharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio
  90. 7.15.5 Tianjin Junan Biopharmaceutical Co., Ltd. Recent Developments
  91. 7.16 Chongqing Laimi Pharmaceutical Co., Ltd.
  92. 7.16.1 Chongqing Laimi Pharmaceutical Co., Ltd. Company Information
  93. 7.16.2 Chongqing Laimi Pharmaceutical Co., Ltd. Business Overview
  94. 7.16.3 Chongqing Laimi Pharmaceutical Co., Ltd. Rifaximin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Chongqing Laimi Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio
  96. 7.16.5 Chongqing Laimi Pharmaceutical Co., Ltd. Recent Developments
  97. 7.17 Chongqing Sino Biopharmaceutical Co., Ltd.
  98. 7.17.1 Chongqing Sino Biopharmaceutical Co., Ltd. Company Information
  99. 7.17.2 Chongqing Sino Biopharmaceutical Co., Ltd. Business Overview
  100. 7.17.3 Chongqing Sino Biopharmaceutical Co., Ltd. Rifaximin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Chongqing Sino Biopharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio
  102. 7.17.5 Chongqing Sino Biopharmaceutical Co., Ltd. Recent Developments
8 North America
  1. 8.1 North America Rifaximin Tablets Market Size by Type
  2. 8.1.1 North America Rifaximin Tablets Revenue by Type (2021-2032)
  3. 8.1.2 North America Rifaximin Tablets Sales by Type (2021-2032)
  4. 8.1.3 North America Rifaximin Tablets Price by Type (2021-2032)
  5. 8.2 North America Rifaximin Tablets Market Size by Application
  6. 8.2.1 North America Rifaximin Tablets Revenue by Application (2021-2032)
  7. 8.2.2 North America Rifaximin Tablets Sales by Application (2021-2032)
  8. 8.2.3 North America Rifaximin Tablets Price by Application (2021-2032)
  9. 8.3 North America Rifaximin Tablets Market Size by Country
  10. 8.3.1 North America Rifaximin Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Rifaximin Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Rifaximin Tablets Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Rifaximin Tablets Market Size by Type
  2. 9.1.1 Europe Rifaximin Tablets Revenue by Type (2021-2032)
  3. 9.1.2 Europe Rifaximin Tablets Sales by Type (2021-2032)
  4. 9.1.3 Europe Rifaximin Tablets Price by Type (2021-2032)
  5. 9.2 Europe Rifaximin Tablets Market Size by Application
  6. 9.2.1 Europe Rifaximin Tablets Revenue by Application (2021-2032)
  7. 9.2.2 Europe Rifaximin Tablets Sales by Application (2021-2032)
  8. 9.2.3 Europe Rifaximin Tablets Price by Application (2021-2032)
  9. 9.3 Europe Rifaximin Tablets Market Size by Country
  10. 9.3.1 Europe Rifaximin Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Rifaximin Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Rifaximin Tablets Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Rifaximin Tablets Market Size by Type
  2. 10.1.1 China Rifaximin Tablets Revenue by Type (2021-2032)
  3. 10.1.2 China Rifaximin Tablets Sales by Type (2021-2032)
  4. 10.1.3 China Rifaximin Tablets Price by Type (2021-2032)
  5. 10.2 China Rifaximin Tablets Market Size by Application
  6. 10.2.1 China Rifaximin Tablets Revenue by Application (2021-2032)
  7. 10.2.2 China Rifaximin Tablets Sales by Application (2021-2032)
  8. 10.2.3 China Rifaximin Tablets Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Rifaximin Tablets Market Size by Type
  2. 11.1.1 Asia Rifaximin Tablets Revenue by Type (2021-2032)
  3. 11.1.2 Asia Rifaximin Tablets Sales by Type (2021-2032)
  4. 11.1.3 Asia Rifaximin Tablets Price by Type (2021-2032)
  5. 11.2 Asia Rifaximin Tablets Market Size by Application
  6. 11.2.1 Asia Rifaximin Tablets Revenue by Application (2021-2032)
  7. 11.2.2 Asia Rifaximin Tablets Sales by Application (2021-2032)
  8. 11.2.3 Asia Rifaximin Tablets Price by Application (2021-2032)
  9. 11.3 Asia Rifaximin Tablets Market Size by Country
  10. 11.3.1 Asia Rifaximin Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Rifaximin Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Rifaximin Tablets Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Rifaximin Tablets Market Size by Type
  2. 12.1.1 SAMEA Rifaximin Tablets Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Rifaximin Tablets Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Rifaximin Tablets Price by Type (2021-2032)
  5. 12.2 SAMEA Rifaximin Tablets Market Size by Application
  6. 12.2.1 SAMEA Rifaximin Tablets Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Rifaximin Tablets Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Rifaximin Tablets Price by Application (2021-2032)
  9. 12.3 SAMEA Rifaximin Tablets Market Size by Country
  10. 12.3.1 SAMEA Rifaximin Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Rifaximin Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Rifaximin Tablets Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Rifaximin Tablets Value Chain Analysis
  2. 13.1.1 Rifaximin Tablets Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Rifaximin Tablets Production Mode & Process
  6. 13.2 Rifaximin Tablets Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Rifaximin Tablets Distributors
  9. 13.2.3 Rifaximin Tablets Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst